The TEAMMATE Trial: Study Design and Rationale of the First Pediatric Heart Transplant Randomized Clinical Trial.

C. Almond; L.A. Sleeper; J.W. Rossano; E. Pahl; A.K. Lal; C.D. Castleberry; J. Lee; S. Hollander; G. Klein; L.M. Barkoff; M. Fenton; M. Bock; K.P. Daly; Matthew J. Bock

doi:10.1016/J.HEALUN.2020.01.825

The TEAMMATE Trial: Study Design and Rationale of the First Pediatric Heart Transplant Randomized Clinical Trial.

C. Almond, L.A. Sleeper, J.W. Rossano, E. Pahl, A.K. Lal, C.D. Castleberry, J. Lee, S. Hollander, G. Klein, L.M. Barkoff, M. Fenton, M. Bock, K.P. Daly, Matthew J. Bock

Loma Linda University Health

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Heart and Lung Transplantation
Volume	39
DOIs	https://doi.org/10.1016/J.HEALUN.2020.01.825
State	Published - Mar 30 2020

Disciplines

Internal Medicine
Medicine and Health Sciences

Access to Document

10.1016/J.HEALUN.2020.01.825License: Unspecified

OpenUrl availability

Full text

Cite this

Almond, C., Sleeper, L. A., Rossano, J. W., Pahl, E., Lal, A. K., Castleberry, C. D., Lee, J., Hollander, S., Klein, G., Barkoff, L. M., Fenton, M., Bock, M., Daly, K. P., & Bock, M. J. (2020). The TEAMMATE Trial: Study Design and Rationale of the First Pediatric Heart Transplant Randomized Clinical Trial. Journal of Heart and Lung Transplantation, 39. https://doi.org/10.1016/J.HEALUN.2020.01.825

Almond, C, Sleeper, LA, Rossano, JW, Pahl, E, Lal, AK, Castleberry, CD, Lee, J, Hollander, S, Klein, G, Barkoff, LM, Fenton, M, Bock, M, Daly, KP & Bock, MJ 2020, 'The TEAMMATE Trial: Study Design and Rationale of the First Pediatric Heart Transplant Randomized Clinical Trial.', Journal of Heart and Lung Transplantation, vol. 39. https://doi.org/10.1016/J.HEALUN.2020.01.825

@article{114bd0fc8fa74d8294d0db785e513e56,

title = "The TEAMMATE Trial: Study Design and Rationale of the First Pediatric Heart Transplant Randomized Clinical Trial.",

author = "C. Almond and L.A. Sleeper and J.W. Rossano and E. Pahl and A.K. Lal and C.D. Castleberry and J. Lee and S. Hollander and G. Klein and L.M. Barkoff and M. Fenton and M. Bock and K.P. Daly and Bock, {Matthew J.}",

note = "Currently there are no-FDA approved immunosuppressants specific to pediatric heart transplantation (HT). In recent years, everolimus (EVL) has emerged as an alternative to tacrolimus (TAC) as a primary immunosuppressant to prevent rejection that may also prevent kidney and coronary disease. However, the two regimens have never been evaluated systematically.",

year = "2020",

month = mar,

day = "30",

doi = "10.1016/J.HEALUN.2020.01.825",

language = "American English",

volume = "39",

journal = "Journal of Heart and Lung Transplantation",

}

TY - JOUR

T1 - The TEAMMATE Trial: Study Design and Rationale of the First Pediatric Heart Transplant Randomized Clinical Trial.

AU - Almond, C.

AU - Sleeper, L.A.

AU - Rossano, J.W.

AU - Pahl, E.

AU - Lal, A.K.

AU - Castleberry, C.D.

AU - Lee, J.

AU - Hollander, S.

AU - Klein, G.

AU - Barkoff, L.M.

AU - Fenton, M.

AU - Bock, M.

AU - Daly, K.P.

AU - Bock, Matthew J.

N1 - Currently there are no-FDA approved immunosuppressants specific to pediatric heart transplantation (HT). In recent years, everolimus (EVL) has emerged as an alternative to tacrolimus (TAC) as a primary immunosuppressant to prevent rejection that may also prevent kidney and coronary disease. However, the two regimens have never been evaluated systematically.

PY - 2020/3/30

Y1 - 2020/3/30

UR - https://www.sciencedirect.com/science/article/pii/S1053249820308421

U2 - 10.1016/J.HEALUN.2020.01.825

DO - 10.1016/J.HEALUN.2020.01.825

M3 - Article

VL - 39

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

ER -

The TEAMMATE Trial: Study Design and Rationale of the First Pediatric Heart Transplant Randomized Clinical Trial.

Disciplines

Access to Document

OpenUrl availability

Other files and links

Cite this